FDNA is transforming rare disease diagnosis by leveraging AI, facial recognition, and phenotyping, empowering over 70% of the world’s clinical geneticists. CBC helped simplify the company’s complex scientific message, crafting a media strategy that resonated with investors, physicians, and press alike. Over the course of one year, CBC secured more than 300 media placements across healthcare, business, and tech outlets, generating over 580M impressions. This elevated FDNA’s profile, growing its global network and establishing its platform as a key player in genomic research